abstract |
The invention relates to the use of an AT 1 receptor antagonist or or an AT 2 receptornmodulator, respectively, or a pharmaceutically acceptable salt thereof, for producing anpharmaceutical preparation for the treatment of conditions or diseases associated with thenincrease of AT 1 receptors in the sub-epithelial area or increase of AT 2 receptors in thenepithelia. |